Announcements Trials
Browse Landscape

Phase

Phase 2 101Phase 1 85Phase NA 56Phase 1/2 52Phase 3 26Phase EARLY_PHASE1 10Phase 4 6Phase 2/3 3

Status

Recruiting 93Active not recruiting 35Not yet recruiting 25Completed 9Suspended 4Terminated 3Enrolling by invitation 3Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Dermatologic 1

Conditions

Skin Neoplasms 1Pleural Effusion 1Pancreatic Neoplasms 1Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 1Tenecteplase 1Surgical Procedures, Operative 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Terminated × 90 days × Clear all
NCT06295809 2026-05-08

INTerpath-007

Merck Sharp & Dohme LLC

Phase 2/3 Terminated
46 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

NCT01580618 2026-04-14

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Kaiser Permanente

Phase 2/3 Terminated
20 enrolled 11 charts
Thoracic

Neoplasms, Pleural Effusion

NCT05131776 2026-03-23

EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.

Chinese University of Hong Kong

Phase 2/3 Terminated
2 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡